4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0000950170-25-024111
Options or other derivatives
- Chief Financial Officer acquired 225,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Delfini Lisa Chief Financial Officer | 2025-02-18 | Grant or award · Stock Option (right to buy) | +225,500 | 225,500 | D | ||
Loading xslF345X05/ownership.xml…